Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Skandinavisk BioTech AB
AB
Active
Org 5565761763
Gamla Orbadenvägen 2, 821 67
Vallsta
Manufacture of oils and fats
·
NACE 1041
Est. 1999 · 26 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of oils and fats
/
Skandinavisk BioTech AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
7M
6M
4M
2M
0M
2021: 4M
4M
2021
2022: 6M (+50% vs 2021)
6M
+50%
2022
2023: 6M (0% vs 2022)
6M
0%
2023
2024: 6M (0% vs 2023)
6M
0%
2024
2025: 5M (-17% vs 2024)
5M
-17%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
4 676
5 834
5 978
6 085
4 016
Staff expenses
—
—
—
—
—
EBITDA
764
1 405
718
956
1 040
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
764
1 405
718
956
1 040
Net financials
792
113
103
10
40
Profit before tax
1 362
2 461
651
721
1 059
Tax
−120
−417
−140
−152
−242
Net profit
1 242
2 044
511
569
817
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
2 287
5 648
9 614
8 774
7 491
Equity
1 362
2 248
7 205
6 694
6 125
Long-term debt
0
0
0
0
0
Short-term debt
731
3 399
1 004
905
497
Total debt
731
3 399
1 004
905
497
Financial ratios
5-year trend
EBITDA margin
16,3 %
This company
15,8 %
Market median
This company
Market median
3% above market
2021
2025
Equity ratio
59,6 %
This company
38,2 %
Market median
This company
Market median
56% above market
2021
2025
Return on equity
91,2 %
This company
18,4 %
Market median
This company
Market median
396% above market
2021
2025
Net profit margin
26,6 %
This company
8,1 %
Market median
This company
Market median
228% above market
2021
2025
Asset turnover
2,04×
This company
1,12×
Market median
This company
Market median
82% above market
2021
2025
Debt / equity
0,68×
This company
0,62×
Market median
This company
Market median
10% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
View
PDF
More on Skandinavisk BioTech AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
